Core Laboratories Inc.
CLBNYSECIK 1958086EnergyFiscal year ends Dec 31
Reports and events: 41 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2520:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-365271 |
| 2026-07-3021:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-326345 |
| 2026-07-2920:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324101 |
| 2026-05-1320:54 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-221857 |
| 2026-05-0122:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-198109 |
| 2026-04-2920:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-192018 |
| 2026-03-3121:21 ET | DEF 14A | Proxy statementPeriod 2026-03-31 | 0001193125-26-134986 |
| 2026-03-2320:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-119934 |
| 2026-03-2301:54 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-118177 |
| 2026-03-1710:15 ET | 8-K/A | 2.02 Results of operations | 0001193125-26-109251 |
| 2026-03-0521:11 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-093962 |
| 2026-02-0421:58 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-037789 |
| 2025-10-2320:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-248736 |
| 2025-10-2220:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-246793 |
| 2025-07-2522:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-098473 |
| 2025-07-2320:20 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-097897 |
| 2025-05-2720:27 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-077738 |
| 2025-04-2822:36 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-058900 |
| 2025-04-2320:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-057483 |
| 2025-03-3120:58 ET | DEF 14A | Proxy statementPeriod 2025-03-31 | 0000950170-25-047865 |
| 2025-02-1323:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-019072 |
| 2025-01-2921:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-010552 |
| 2024-10-2421:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-117122 |
| 2024-10-2320:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-116676 |
| 2024-07-2521:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-086610 |
| 2024-07-2420:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-086092 |
| 2024-05-1021:01 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-057934 |
| 2024-04-2520:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-048414 |
| 2024-04-2420:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-047646 |
| 2024-03-2520:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-035962 |
| 2024-03-1922:07 ET | DEF 14A | Proxy statementPeriod 2024-03-18 | 0000950170-24-033021 |
| 2024-02-1500:08 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-015483 |
| 2024-02-1500:06 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-015482 |
| 2024-01-3122:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-009489 |
| 2023-11-0220:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058206 |
| 2023-11-0120:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-057543 |
| 2023-07-2721:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-035213 |
| 2023-07-2620:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-034753 |
| 2023-07-1821:15 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-23-033405 |
| 2023-07-0321:40 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-031189 |
| 2023-05-0501:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-018053 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.